BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16619570)

  • 21. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
    Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Weis B; Ben-Baruch G; Reich R
    Gynecol Oncol; 1999 Mar; 72(3):380-6. PubMed ID: 10053110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TIMP-2 gene methylation in cervical precursor and invasive lesions.
    Furtado Y; Almeida G; Silveira FA; Silva KS; Maldonado P; do Val IC; Cavalcanti S; L MA; Carvalho Mda G
    Exp Mol Pathol; 2015 Feb; 98(1):119-23. PubMed ID: 25579181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
    Costa S; De Simone P; Venturoli S; Cricca M; Zerbini ML; Musiani M; Terzano P; Santini D; Cristiani P; Syrjänen S; Syrjänen K
    Gynecol Oncol; 2003 Aug; 90(2):358-65. PubMed ID: 12893200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
    Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
    Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
    Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
    Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables.
    Kruse AJ; Baak JP; Janssen EA; Bol MG; Kjellevold KH; Fianne B; Lovslett K; Bergh J
    J Pathol; 2003 Apr; 199(4):462-70. PubMed ID: 12635137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K
    Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
    Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
    Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
    Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
    Virchows Arch; 2009 Dec; 455(6):505-15. PubMed ID: 19908064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation.
    Talvensaari A; Apaja-Sarkkinen M; Höyhtyä M; Westerlund A; Puistola U; Turpeenniemi T
    Gynecol Oncol; 1999 Mar; 72(3):306-11. PubMed ID: 10053100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
    Söderlund-Strand A; Rymark P; Andersson P; Dillner J; Dillner L
    J Clin Microbiol; 2005 Jul; 43(7):3260-6. PubMed ID: 16000445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Biagini G
    Gynecol Oncol; 1996 May; 61(2):197-203. PubMed ID: 8626132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
    Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
    Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate, Egypt.
    Abd El-Azim S; Lotfy M; Omr A
    Clin Lab; 2011; 57(5-6):363-71. PubMed ID: 21755827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia.
    Bekkers RL; Melchers WJ; Bakkers JM; Hanselaar AG; Quint WG; Boonstra H; Massuger LF
    Int J Cancer; 2002 Nov; 102(2):148-51. PubMed ID: 12385010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
    Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
    Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the correlation between the different papillomavirus type and telomerase in cervical cancer].
    Lv W; Zhang GM; Sui LH; Wang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Oct; 24(10):924-7. PubMed ID: 14575610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.